Integra LifeSciences bought SeaSpine, a spinal fusion device company, for $89 million in cash. The combination of SeaSpine's portfolio with Integra LifeSciences' existing spine business will make its spine and orthobiologics portfolio the largest component of the company.
Interventional Spine and DSM Biomedical entered into a license and supply agreement which allows Interventional Spine to use DSM proprietary polymer Bionate PCU in its Percutaneous Dynamic Stabilization system. Terms of the agreement were not disclosed but contain a mix of royalties on devices sold and annual fees.
InVivo Therapeutics, company that develops treatment for spinal cord injury, partnered with the University of Miami Miller School of Medicine's Miami Project to Cure Paralysis. The partnership will promote research and development of cellular therapies, including InVivo's biopolymer scaffolding designed to mimic natural protective properties of the extracellular matrix within the spinal cord and promote the proliferation and survival of implanted cells.
Johnson & Johnson acquired Synthes for $21.3 billion. The DePuy Family of Companies, a J&J subsidiary, will merge its orthopedics portfolio with Synthes' innovations in trauma, spine cranio-maxillofacial and power tools.
Kensey Nash recently acquired the assets of Synthes subsidiary Norian for $22 million. Kensey Nash will manufacture Norian produces and Synthes will exclusively distribute them.
OrthoSensor, a developer of intelligent orthopedic devices, has partnered with CareCloud, a healthcare software company, to provide evidence-based data to physicians and hospitals. The CareCloud technology will assist OrthoSensor in collecting and reporting clinical data with the ability to integrate real-time data.
Premia Spine, a spine device company, has acquired assets of Impliant, which includes 16 worldwide patents. Premia plans to commercially launch the TOPS System and its adjunct Versalink Fixation System during the third quarter of 2011.
Stryker entered into a merger agreement with Orthovita, acquiring the company's common stock for $316 million. Stryker will commence an all-cash tender offer to acquire Orthovita's outstanding common stock as well, and acquire the remaining outstanding shares through a second merger.
Related Articles on Orthopedic and Spine Device Companies:
Lawsuit Against DePuy’s Pinnacle Hip Implant Consolidated in Texas
Medtronic Reports 19% Decrease in 4Q Net Income to $776M
Tornier Introduces Affiniti Stem for Shoulder Surgery
Interventional Spine and DSM Biomedical entered into a license and supply agreement which allows Interventional Spine to use DSM proprietary polymer Bionate PCU in its Percutaneous Dynamic Stabilization system. Terms of the agreement were not disclosed but contain a mix of royalties on devices sold and annual fees.
InVivo Therapeutics, company that develops treatment for spinal cord injury, partnered with the University of Miami Miller School of Medicine's Miami Project to Cure Paralysis. The partnership will promote research and development of cellular therapies, including InVivo's biopolymer scaffolding designed to mimic natural protective properties of the extracellular matrix within the spinal cord and promote the proliferation and survival of implanted cells.
Johnson & Johnson acquired Synthes for $21.3 billion. The DePuy Family of Companies, a J&J subsidiary, will merge its orthopedics portfolio with Synthes' innovations in trauma, spine cranio-maxillofacial and power tools.
Kensey Nash recently acquired the assets of Synthes subsidiary Norian for $22 million. Kensey Nash will manufacture Norian produces and Synthes will exclusively distribute them.
OrthoSensor, a developer of intelligent orthopedic devices, has partnered with CareCloud, a healthcare software company, to provide evidence-based data to physicians and hospitals. The CareCloud technology will assist OrthoSensor in collecting and reporting clinical data with the ability to integrate real-time data.
Premia Spine, a spine device company, has acquired assets of Impliant, which includes 16 worldwide patents. Premia plans to commercially launch the TOPS System and its adjunct Versalink Fixation System during the third quarter of 2011.
Stryker entered into a merger agreement with Orthovita, acquiring the company's common stock for $316 million. Stryker will commence an all-cash tender offer to acquire Orthovita's outstanding common stock as well, and acquire the remaining outstanding shares through a second merger.
Related Articles on Orthopedic and Spine Device Companies:
Lawsuit Against DePuy’s Pinnacle Hip Implant Consolidated in Texas
Medtronic Reports 19% Decrease in 4Q Net Income to $776M
Tornier Introduces Affiniti Stem for Shoulder Surgery